FDA Drug Application (021271) for IPRIVASK by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number021271
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage15MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameIPRIVASK
Active IngredientDESIRUDIN RECOMBINANT



Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.